Nishaminy Kasbekar

908 total citations
13 papers, 602 citations indexed

About

Nishaminy Kasbekar is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Nishaminy Kasbekar has authored 13 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Molecular Medicine. Recurrent topics in Nishaminy Kasbekar's work include Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pneumonia and Respiratory Infections (2 papers). Nishaminy Kasbekar is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pneumonia and Respiratory Infections (2 papers). Nishaminy Kasbekar collaborates with scholars based in United States and France. Nishaminy Kasbekar's co-authors include Bruce H. Ackerman, Jeffrey S. Berns, William E. Smoyer, Deborah A. Pasko, William M. Bennett, George R. Aronoff, Michael E. Brier, Bruce A. Mueller, Lori A. LaRosa and Neil O. Fishman and has published in prestigious journals such as American Journal of Public Health, Clinical Journal of the American Society of Nephrology and Infection Control and Hospital Epidemiology.

In The Last Decade

Nishaminy Kasbekar

13 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nishaminy Kasbekar United States	10	121	110	106	104	94	13	602
D E Stableforth United Kingdom	24	371 3.1×	120 1.1×	52 0.5×	70 0.7×	28 0.3×	73	2.0k
P Davey United Kingdom	9	173 1.4×	45 0.4×	66 0.6×	114 1.1×	6 0.1×	19	601
Angèle P. M. Kerckhoffs Netherlands	13	120 1.0×	27 0.2×	12 0.1×	212 2.0×	45 0.5×	26	948
Cary E. Johnson United States	17	78 0.6×	165 1.5×	6 0.1×	59 0.6×	31 0.3×	86	818
Alison Kent Australia	16	258 2.1×	81 0.7×	8 0.1×	45 0.4×	50 0.5×	35	867
Barry T. Bloom United States	22	413 3.4×	159 1.4×	5 0.0×	189 1.8×	315 3.4×	34	1.7k
Rachel G. Greenberg United States	25	508 4.2×	100 0.9×	6 0.1×	98 0.9×	229 2.4×	161	1.9k
Luis S. Gonzalez United States	8	86 0.7×	46 0.4×	12 0.1×	16 0.2×	6 0.1×	13	370
Julian Schilling Switzerland	11	202 1.7×	55 0.5×	3 0.0×	276 2.7×	90 1.0×	36	829
Fabrice Ruiz France	13	186 1.5×	22 0.2×	25 0.2×	45 0.4×	35 0.4×	33	548

Countries citing papers authored by Nishaminy Kasbekar

Since Specialization

Citations

This map shows the geographic impact of Nishaminy Kasbekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishaminy Kasbekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishaminy Kasbekar more than expected).

Fields of papers citing papers by Nishaminy Kasbekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nishaminy Kasbekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishaminy Kasbekar. The network helps show where Nishaminy Kasbekar may publish in the future.

Co-authorship network of co-authors of Nishaminy Kasbekar

This figure shows the co-authorship network connecting the top 25 collaborators of Nishaminy Kasbekar. A scholar is included among the top collaborators of Nishaminy Kasbekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nishaminy Kasbekar. Nishaminy Kasbekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lee, Kevin, et al.. (2022). Leveraging ambulatory care pharmacist expertise in medication appeals to overcome access barriers: A descriptive report. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(11). 1128–1138. 2 indexed citations

Klusaritz, Heather, Nawar Naseer, Neda Haseeb Khan, et al.. (2022). Community-Based COVID-19 Vaccine Clinics in Medically Underserved Neighborhoods to Improve Access and Equity, Philadelphia, 2021–2022. American Journal of Public Health. 112(12). 1721–1725. 4 indexed citations

Green-McKenzie, Judith, Frances S. Shofer, Florence Momplaisir, et al.. (2021). Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability. JAMA Network Open. 4(12). e2136582–e2136582. 23 indexed citations

Feldman, Adina L., et al.. (2018). Impact of comprehensive pharmacy services on patient centered outcomes in a hematology and oncology clinic. 7(sup1). 20–20. 3 indexed citations

Aronoff, George R., William M. Bennett, Jeffrey S. Berns, et al.. (2007). Drug prescribing in renal failure : dosing guidelines for adults and children. 133 indexed citations

Israni, Rubeen, Nishaminy Kasbekar, Kevin Haynes, & Jeffrey S. Berns. (2006). Use of Antiepileptic Drugs in Patients with Kidney Disease. Seminars in Dialysis. 19(5). 408–416. 35 indexed citations

Kasbekar, Nishaminy. (2006). Tigecycline: A new glycylcycline antimicrobial agent. American Journal of Health-System Pharmacy. 63(13). 1235–1243. 59 indexed citations

Kasbekar, Nishaminy, et al.. (2006). HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: The Safety of Heparins in End‐Stage Renal Disease. Seminars in Dialysis. 19(4). 305–310. 26 indexed citations

Lipworth, Adam D., Emily P. Hyle, Neil O. Fishman, et al.. (2006). Limiting the Emergence of Extended-Spectrumβ–Lactamase-Producing Enterobacteriaceae: Influence of Patient Population Characteristics on the Response to Antimicrobial Formulary Interventions. Infection Control and Hospital Epidemiology. 27(3). 279–286. 34 indexed citations

10.

Berns, Jeffrey S. & Nishaminy Kasbekar. (2005). Highly Active Antiretroviral Therapy and the Kidney. Clinical Journal of the American Society of Nephrology. 1(1). 117–129. 48 indexed citations

11.

Kasbekar, Nishaminy, et al.. (2005). Telithromycin: The first ketolide for the treatment of respiratory infections. American Journal of Health-System Pharmacy. 62(9). 905–916. 14 indexed citations

12.

Lautenbach, Ebbing, et al.. (2003). Fluoroquinolone Utilization in the Emergency Departments of Academic Medical Centers. Archives of Internal Medicine. 163(5). 601–601. 74 indexed citations

13.

Ackerman, Bruce H. & Nishaminy Kasbekar. (1997). Disturbances of Taste and Smell Induced by Drugs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(3). 482–496. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact